Lµbris BioPharma is a biopharmaceutical company developing recombinant human lubricin for the treatment of dry eye, osteoarthritis, post-surgical adhesions and other age & inflammation-related conditions. Lubricin functions like biologic Teflon® – it is naturally produced throughout the human body protecting tissues and other surfaces from friction-related damage and wear. Supplementation with recombinant human lubricin is an innovative and exciting new approach to disease management.www.lubris.net

KitoTech Medical is a Seattle-based medical device company that has developed microMend, a unique wound closure device. The product is an FDA Class 1 medical device listed with FDA and available for sale in the United States. Clinical studies are demonstrating outstanding clinical results and strong physician and patient preferences for microMend over sutures for closing wounds.

Merged with Lubris BioPharmawww.singularis.com

Biological Dynamics has developed proprietary, patented platforms for direct and selective capture of large necrotic particles in physiological solutions. Large necrotic particles, including cell-free nucleic acids (cfDNA), have been established as biomarkers of necrosis, cancer and inflammation, and tracking of these biomarkers has been demonstrated to predict efficacy of cancer therapeutics. Utilizing this technology, one can isolate, fluorescently quantify and report on circulating biomarkers, providing the ability to deliver rapid, point-of-care actionable results for assistance with treatment monitoring and early diagnosis of disease.

Providing Outside General Counsel and Litigation services to San Diego's Emerging Business Community